Curis, Inc. (NASDAQ:CRIS) marched up 58.33% compared to a 52-week low price of $0.6. The shares were last seen trading -3.06% lower, taking the closing price at $0.95 on 01/11/2019. At recent session, the prices were hovering between $0.92 and $1.0391. This company shares are 531.58% off its target price of $6 and the current market capitalization stands at $32.5M. The recent change has given its price a -13.09% deficit over SMA 50 and -81.73% deficit over its 52-week high. The stock witnessed 53.2% gains, -50.78% declines and -49.2% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CRIS’s volatility during a week at 14.97% and during a month it has been found around 13.97%.Curis, Inc. (CRIS) Top Holders
Institutional investors currently hold around $9 million or 26.5% in CRIS stock. Look at its top three institutional owners. First Eagle Investment Management, Llc owns $4.73 million in Curis, Inc., which represents roughly 14.56% of the company’s market cap and approximately 52.58% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 1,091,844 shares of the stock are valued at $1.04 million. The third largest holder is Blackrock Inc., which currently holds $757 thousand worth of this stock and that ownership represents nearly 2.33% of its market capitalization.
At the end of September reporting period, 18 institutional holders increased their position in Curis, Inc. (NASDAQ:CRIS) by some 324,033 shares, 40 decreased positions by 1,566,579 and 12 held positions by 7,969,577. That puts total institutional holdings at 9,860,189 shares, according to SEC filings. The stock grabbed 9 new institutional investments totaling 93,604 shares while 16 institutional investors sold out their entire positions totaling 776,956 shares.Curis, Inc. (NASDAQ:CRIS) Insider Trades
Multiple company employees have indulged in significant insider trading. Curis, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Rubin Marc has acquired 5,000 shares of Curis, Inc. (CRIS) in trading session dated Nov. 16, 2017. These shares are worth $24,500 and were traded at $4.9 each. The SEC filing shows that Fattaey Ali Ph.D. performed a purchase of 10,000 shares. The President & CEO added these shares by way of transaction on Nov. 15, 2017. The company’s shares were assimilated at $5.3 per share worth to an investment of some $53,000 on account of Fattaey Ali Ph.D..
Director, Mcnab James R, sold 15,255 common shares of Curis, Inc. (CRIS) in the open market. In a transaction dated May. 05, 2017, the shares were put up for sale at an average price of $10.2, raking in a sum of $155,601. After this sale, 185,938 common shares of CRIS are directly owned by the insider, with total stake valued at $176,641.
In the transaction dated May. 05, 2017, the great number of shares disposed came courtesy the Director; Mcnab James R disposed a total of 15,255 shares at an average price of $10.2, amounting to approximately $155,601. The insider now directly owns 185,938 shares worth $176,641.
Several analysts have released their opinion on Curis, Inc. (NASDAQ:CRIS), with 2 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.33 average brokerage recommendation.